Snapshot from Aug 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Antibody Therapeutics Market Forecast 2035
Business Market Forecast

Antibody Therapeutics Market Forecast 2035

Analysis based on 7 articles · First reported Jul 28, 2026 · Last updated Jul 29, 2026

Sentiment
30
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The forecast indicates sustained growth in the antibody therapeutics market, benefiting major pharmaceutical companies with strong biologics pipelines. Investors may see positive sentiment for companies like AbbVie, Merck & Co., and Roche, while the overall sector outlook remains favorable.

Pharmaceuticals Biotechnology
Event Summary

MarketsandMarkets published a report projecting the global antibody therapeutics market to grow from USD 311.2 billion in 2026 to USD 597.1 billion by 2035, at a CAGR of 7.5%. The report highlights the dominance of monoclonal antibodies, the shift toward next-generation formats like bispecific antibodies and ADCs, and North America's leading market share. Key players include AbbVie, Merck & Co., Novartis, Bristol Myers Squibb, Johnson & Johnson, Roche, Sanofi, Amgen, Regeneron Pharmaceuticals, and Boehringer Ingelheim.

Entities Involved
priv
MarketsandMarkets
MarketsandMarkets published the market forecast report, serving as the source of the event.
Importance 100.0 Sentiment 0.0
stock
AbbVie
AbbVie is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Importance 80.0 Sentiment 40.0
stock
Merck & Co.
Merck & Co. is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Importance 80.0 Sentiment 40.0
stock
Novartis
Novartis is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Importance 80.0 Sentiment 40.0
stock
Bristol Myers Squibb
Bristol Myers Squibb is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Importance 80.0 Sentiment 40.0
stock
Johnson & Johnson
Johnson & Johnson is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Importance 80.0 Sentiment 40.0
stock
Roche
Roche is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Importance 80.0 Sentiment 40.0
stock
Sanofi
Sanofi is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Importance 80.0 Sentiment 40.0
stock
Amgen
Amgen is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Importance 80.0 Sentiment 40.0
stock
Regeneron Pharmaceuticals
Regeneron is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Importance 80.0 Sentiment 40.0
priv
Boehringer Ingelheim
Boehringer Ingelheim is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Importance 80.0 Sentiment 40.0
cnt
United States
The US is part of North America, which held the largest market share in 2025, supported by strong regulatory frameworks and advanced manufacturing.
Importance 60.0 Sentiment 30.0
govactor
United States — Food and Drug Administration
The US FDA provides supportive regulatory frameworks that facilitate product approvals and market growth in North America.
Importance 40.0 Sentiment 20.0
cnt
Canada
Canada, through Canada — Health Canada, contributes to the supportive regulatory environment in North America.
Importance 40.0 Sentiment 30.0
cnt
Switzerland
Switzerland is the home country of key players Novartis and Roche, which are major participants in the market.
Importance 30.0 Sentiment 20.0
+ 3 more entities View on Dashboard
Relationships
MarketsandMarkets related ↔ Roche
Merck & Co. related ↔ Bristol Myers Squibb
Merck & Co. related ↔ Sanofi
Merck & Co. related ↔ Amgen
Merck & Co. related ↔ Regeneron Pharmaceuticals
Novartis related ↔ Roche
Novartis related ↔ Sanofi
Novartis related ↔ Amgen
Johnson & Johnson related ↔ Sanofi
Roche related ↔ Sanofi
Sanofi related ↔ Amgen
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.